Connie M. Sears - Concepedia

Author

Connie M. Sears

Stanford University ORCID

Also Known As

Connie M Sears, Connie M. Sears, Connie Martin Sears, Connie Sears

Publications

574

Citations

H-Index

Concepts

All Affiliations

Stanford University University of California, Los Angeles Harvard University VA Greater Los Angeles Healthcare System Palo Alto University

About

Connie M. Sears is an author at Stanford University specializing in medicine, ophthalmology, and diabetic retinopathy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	236
2	Arts	1	1	76
3	Engineering	1	1	78
4	Biomedical Engineering	1	1	78
5	Cell Biology	1	1	78

Connie M. Sears

Publications

527

Citations

H-Index

Page 1

	Year	Citations
Type I Collagen as an Extracellular Matrix for the In Vitro Growth of Human Small Intestinal Epithelium Ziyad Jabaji, Garrett J. Brinkley, Hassan A. Khalil, PLoS ONE	2014	119
Use of Collagen Gel as an Alternative Extracellular Matrix for the <i>In Vitro</i> and <i>In Vivo</i> Growth of Murine Small Intestinal Epithelium Ziyad Jabaji, Connie M. Sears, Garrett J. Brinkley, Tissue Engineering Part C Methods Tissue EngineeringEngineeringGreen Fluorescent ProteinCell CultureBiomedical Engineering	2013	78
Hearing Dysfunction After Treatment With Teprotumumab for Thyroid Eye Disease Connie M. Sears, Amee D. Azad, Linus Amarikwa, American Journal of Ophthalmology OphthalmologyThyroid DiseaseAudiologyThyroid DisordersThyroid Hormone	2022	76
Quantitative Assessment of the Severity of Diabetic Retinopathy Srinivas R. Sadda, Muneeswar Gupta Nittala, Wongsiri Taweebanjongsin, American Journal of Ophthalmology Diabetic RetinopathyOcular DiseaseOphthalmologyDiabetesMedicine	2020	51
Early efficacy of teprotumumab for the treatment of dysthyroid optic neuropathy: A multicenter study Connie M. Sears, Yao Wang, Lucy A. Bailey, American Journal of Ophthalmology Case Reports	2021	51
Teprotumumab for Dysthyroid Optic Neuropathy: Early Response to Therapy Connie M. Sears, Amee D. Azad, Chrysoula Dosiou, Ophthalmic Plastic and Reconstructive Surgery	2020	44
Teprotumumab-Related Adverse Events in Thyroid Eye Disease Shreya Shah, Linus Amarikwa, Connie M. Sears, Ophthalmology Translational MedicineOcular DiseaseOphthalmologyThyroid DiseaseThyroid Hormone	2023	31
Comparison of Subjective Assessment and Precise Quantitative Assessment of Lesion Distribution in Diabetic Retinopathy Connie M. Sears, Muneeswar Gupta Nittala, Chaitra Jayadev, JAMA Ophthalmology	2018	30
Outcomes of Patients With Thyroid Eye Disease Partially Treated With Teprotumumab Tiffany C. Ho, Robi N. Maamari, Andrea L. Kossler, Ophthalmic Plastic and Reconstructive Surgery	2022	21
Teprotumumab for the Treatment of Recalcitrant Thyroid Eye Disease Clara J. Men, Linus Amarikwa, Brandon Pham, Ophthalmic Plastic and Reconstructive Surgery	2023	14

Page 1